Science, Tech, Math › Science Introduction to CRISPR Genome Editing What CRISPR Is and How It's Used to Edit DNA Share Flipboard Email Print CRISPR/Cas is a gene editing complex used in gene therapy and as a diagnostic tool. PASIEKA / Getty Images Science Biology Basics Cell Biology Genetics Organisms Anatomy Physiology Botany Ecology Chemistry Physics Geology Astronomy Weather & Climate By Anne Marie Helmenstine, Ph.D. Chemistry Expert Ph.D., Biomedical Sciences, University of Tennessee at Knoxville B.A., Physics and Mathematics, Hastings College Dr. Helmenstine holds a Ph.D. in biomedical sciences and is a science writer, educator, and consultant. She has taught science courses at the high school, college, and graduate levels. our editorial process Facebook Facebook Twitter Twitter Anne Marie Helmenstine, Ph.D. Updated December 03, 2018 Imagine being able to cure any genetic disease, prevent bacteria from resisting antibiotics, alter mosquitoes so they can't transmit malaria, prevent cancer, or successfully transplant animals organs into people without rejection. The molecular machinery to achieve these goals isn't the stuff of a science fiction novel set in the distant future. These are attainable goals made possible by a family of DNA sequences called CRISPRs. What Is CRISPR? CRISPR (pronounced "crisper") is the acronym for Clustered Regularly Interspaced Short Repeats, a group of DNA sequences found in bacteria that act as a defense system against viruses that could infect a bacterium. CRISPRs are a genetic code that is broken up by "spacers" of sequences from viruses that have attacked a bacterium. If the bacteria encounter the virus again, a CRISPR acts as a sort of memory bank, making it easier to defend the cell. Discovery of CRISPR CRISPRs are repeating DNA sequences. Andrew Brookes / Getty Images The discovery of clustered DNA repeats occurred independently in the 1980s and 1990s by researchers in Japan, the Netherlands, and Spain. The acronym CRISPR was proposed by Francisco Mojica and Ruud Jansen in 2001 to reduce the confusion caused by the use of different acronyms by different research teams in scientific literature. Mojica hypothesized that CRISPRs were a form of bacterial acquired immunity. In 2007, a team led by Philippe Horvath experimentally verified this. It wasn't long before scientists found a way to manipulate and use CRISPRs in the lab. In 2013, the Zhang lab became the first to publish a method of engineering CRISPRs for use in mouse and humane genome editing. How CRISPR Works The CRISPR-CAS9 gene editing complex from Streptococcus pyogenes: The Cas9 nuclease protein uses a guide RNA sequence (pink) to cut DNA at a complementary site (green). MOLEKUUL/SCIENCE PHOTO LIBRARY / Getty Images Essentially, naturally-occurring CRISPR gives a cell seek-and-destroy capability. In bacteria, CRISPR works by transcribing spacer sequences that identify the target virus DNA. One of the enzymes produced by the cell (e.g., Cas9) then binds to the target DNA and cuts it, turning off the target gene and disabling the virus. In the laboratory, Cas9 or another enzyme cuts DNA, while CRISPR tells it where to snip. Rather than use viral signatures, researchers customize CRISPR spacers to seek genes of interest. Scientists have modified Cas9 and other proteins, such as Cpf1, so that they can either cut or else activate a gene. Turning a gene off and on makes it easier for scientists to study the function of a gene. Cutting a DNA sequence makes it easy to replace it with a different sequence. Why Use CRISPR? CRISPR is not the first gene editing tool in the molecular biologist's toolbox. Other techniques for gene editing include zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALENs), and engineered meganucleases from mobile genetic elements. CRISPR is a versatile technique because it's cost-effective, allows for a huge selection of targets, and can target locations inaccessible to certain other techniques. But, the main reason it's a big deal is that it's incredibly simple to design and use. All that's needed is a 20 nucleotide target site, which can be made by constructing a guide. The mechanism and techniques are so easy to understand and use they are becoming standard in undergraduate biology curriculums. Uses of CRISPR CRISPR can be used to develop new drugs used for gene therapy. DAVID MACK / Getty Images Researchers use CRISPR to make cell and animal models to identify genes that cause disease, develop gene therapies, and engineer organisms to have desirable traits. Current research projects include: Applying CRISPR to prevent and treat HIV, cancer, sickle-cell disease, Alzheimer's, muscular dystrophy, and Lyme disease. Theoretically, any disease with a genetic component may be treated with gene therapy.Developing new drugs to treat blindness and heart disease. CRISPR/Cas9 has been used to remove a mutation that causes retinitis pigmentosa.Extending the shelf life of perishable foods, increase the resistance of crops to pests and diseases, and increase nutritional value and yield. For example, a Rutgers University team has used the technique to make grapes resistant to downy mildew.Transplanting pig organs (xenotransplanation) into humans without rejectionBringing back woolly mammoths and perhaps dinosaurs and other extinct speciesMaking mosquitoes resistant to the Plasmodium falciparum parasite that causes malaria Obviously, CRISPR and other genome-editing techniques are controversial. In January 2017, the US FDA proposed guidelines to cover the use of these technologies. Other governments are also working on regulations to balance benefits and risks. Selected References and Further Reading Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P (March 2007). "CRISPR provides acquired resistance against viruses in prokaryotes". Science. 315 (5819): 1709–12. Horvath P, Barrangou R (January 2010). "CRISPR/Cas, the immune system of bacteria and archaea". Science. 327 (5962): 167–70.Zhang F, Wen Y, Guo X (2014). "CRISPR/Cas9 for genome editing: progress, implications and challenges". Human Molecular Genetics. 23(R1): R40–6.